Motion Informatics

Motion Informatics operates across medical devices, health care, therapeutics, wellness, and augmented reality, with a stated focus on neuromuscular rehabilitation. Its named product, the Stimel-03 device, is designed for post-stroke rehabilitation: it detects attempted muscle movement and uses electrical stimulation and feedback to support motor recovery. The company’s described approach combines real-time EMG biofeedback with functional and neuromuscular electrical stimulation, and uses AI to interpret voluntary motor signals and adjust stimulation parameters. It also identifies augmented reality and spatial computing as components of its rehabilitation approach. The company’s categories indicate overlap with digital health, therapeutic devices, and immersive rehabilitation. Its scale and market position are also difficult to benchmark without information on deployments, regulatory clearances, reimbursement, or clinical results.

Motion Informatics’ profile records a founding year of 2000 and places the company in the 11–50 employee band. Its clearest documented financing inflection point is the corporate round announced on Oct 16, 2025, led by Biorad Medisys; no amount is disclosed, and no earlier rounds are listed. On the product side, the Stimel-03 device gives the company a concrete post-stroke rehabilitation offering, while its broader technology description points toward an adaptive platform combining EMG feedback, electrical stimulation, AI-based motor-intent interpretation, and augmented reality. The profile lists two current team members, including CEO Moris Zuker and co-founder Amir Oren-Katzur, but provides no hiring trend or employee-growth timeline. Overall, financing, product scale, and growth momentum remain difficult to quantify.